Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 6
- Countries
- 0
Exclusivity
Patents and exclusivities
6| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8487129 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Nov 2027 |
| 12070513 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Jul 2029 |
| 9861713 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Jul 2029 |
| 8778305 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Sept 2030 |
| 10947197 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Jun 2037 |
| 11851407 | PYLARIFY TRUVUpiflufolastat f-18 | substance, product | Jun 2037 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| PYLARIFY TRUVU | PIFLUFOLASTAT F-18 | injection, intravenous | 85347-001NDA |
Compare
Other companies listing piflufolastat f-18
- Progenics Pharmaceuticals, Inc.0 sites · 1 NDC
Enquiry
Common questions
- Is Aphelion LLC FDA approved?
- Aphelion LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Aphelion LLC make?
- 1 product is listed under Aphelion LLC in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.